Gallium nitrate

Drug Profile

Gallium nitrate

Alternative Names: Calstat; G 4544; G 4544a; Ganite; NSC 15200

Latest Information Update: 09 Mar 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Memorial Sloan-Kettering Cancer Center; National Cancer Institute (USA)
  • Developer Cystic Fibrosis Foundation; Emisphere Technologies; Genta (CEASED); University of Washington
  • Class Antihypercalcaemics; Antineoplastics; Calcium regulators; Heavy metals; Small molecules
  • Mechanism of Action Osteoclast inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Market Withdrawal Malignant hypercalcaemia
  • Discontinued Bone cancer; Infections; Non-Hodgkin's lymphoma; Osteitis deformans; Osteoporosis

Most Recent Events

  • 21 Apr 2010 Pharmacokinetics data from a preliminary clinical trial in Cystic-fibrosis associated respiratory tract infections released by Genta
  • 13 Jan 2010 Preclinical pharmacodynamics data in Osteoporosis released by Genta
  • 03 Jun 2008 Interim pharmacokinetics data from a phase I trial presented at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO-2008) ,
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top